Description
Vinpocetine research nootropic
Vinpocetine is a semisynthetic derivative of vincamine, studied as a PDE1 inhibitor.
Product details
| Compound | Vinpocetine |
|---|---|
| Class | Semisynthetic vincamine derivative |
| Form | Powder; Tablets |
| Strength | 5g; 150mg per tablet/20ct/3g; 150mg per tablet/40ct/6g |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What research has examined
- PDE1 inhibition.
- Cerebral blood flow research.
- Sodium channel research.
Research interest does not establish a proven effect in humans.
Regulatory status
Vinpocetine is licensed in some countries; the FDA has said it is not a lawful dietary ingredient. Supplied as a research chemical only.
Storage and handling
Keep the container tightly closed, at room temperature or cooler, away from moisture and light.
Related research products
Piracetam · HBT1 · Hydrafinil · All nootropic powders
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.